Stock Screener App

Gratuito -

3.038

1.67% 0.038

Pds Biotechnology Corporation (PDSB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Pds Biotechnology Corporation Borsa (PDSB) Ultime notizie

PDS: Updated Results, VERSATILE-002 Phase 2 Trial - ShareCast

PDS Biotech Advances with Promising Versamune® HPV Trial Results - TipRanks

PDS Biotech Announces Updated Results from VERSATILE-002 Phase 2 Clinical Trial Presented at ESMO 2024 - StockTitan

PDS Biotechnology Co. (NASDAQ:PDSB) Receives $14.25 Consensus Target Price from Analysts - MarketBeat

PDS Biotechnology Co. (NASDAQ:PDSB) Given Average Recommendation of “Buy” by Brokerages - Defense World

Aneurysmal Subarachnoid Hemorrhage Drugs Market 95115.59mn Size, Spotlight on Future Potentials (2024-2034) - Talented India

PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 - StockTitan

PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, - openPR

A History of Outperforming Analyst Forecasts and Beating the Odds: PDS Biotechnology Corporation (PDSB) - SETE News

Comparing Moolec Science (NASDAQ:MLEC) & Ross Acquisition Corp II (NYSE:ROSS) - Defense World

Snap-on Incorporated (NYSE:SNA) CFO Aldo John Pagliari Sells 4,473 Shares of Stock - Defense World

Louisiana-Pacific Co. (NYSE:LPX) CEO William Bradley Southern Sells 32,600 Shares of Stock - Defense World

Samsara Inc. (NYSE:IOT) Insider John Bicket Sells 78,128 Shares of Stock - Defense World

PDS Biotechnology (NASDAQ:PDSB) Upgraded to "Strong-Buy" by Alliance Global Partners - MarketBeat

PDS Biotechnology (NASDAQ:PDSB) Given New $7.00 Price Target at Alliance Global Partners - Defense World

PDS Biotechnology (NASDAQ:PDSB) Price Target Raised to $7.00 - MarketBeat

PDS Biotechnology Co. (NASDAQ:PDSB) Given Consensus Rating of "Buy" by Brokerages - MarketBeat

Western Wealth Management LLC Purchases 1,800 Shares of Ares Capital Co. (NASDAQ:ARCC) - Defense World

Recurrent or Metastatic Head and Neck Cancer Pipeline Analysis 2024: Clinical Trials, FDA, EMA, PMDA Approvals - openPR

PDS Biotechnology Co. Forecasted to Earn FY2024 Earnings of ($1.17) Per Share (NASDAQ:PDSB) - MarketBeat

Aixtron Se (OTCMKTS:AIXXF) Sees Significant Decrease in Short Interest - Defense World

Vanguard Group Inc. Has $6.23 Million Stock Position in AstroNova, Inc. (NASDAQ:ALOT) - Defense World

Vanguard Group Inc. Grows Stock Position in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World

PDS Biotechnology Co. Forecasted to Post Q3 2024 Earnings of ($0.28) Per Share (NASDAQ:PDSB) - MarketBeat

Noble Financial Weighs in on PDS Biotechnology Co.’s Q3 2024 Earnings (NASDAQ:PDSB) - Defense World

PDS Biotechnology (NASDAQ:PDSB) Posts Earnings Results - Defense World

PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com Australia

PDS Biotechnology (NASDAQ:PDSB) Announces Earnings Results - MarketBeat

PDS Biotechnology updates market on new equity sales agreement - Investing.com India

PDS Biotechnology: Q2 Earnings Snapshot - Darien Times

NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors USA

NetScientific's PDS Biotech prepares phase 3 trial for VERSATILE-003 - Proactive Investors UK

PDS Biotechnology: Q2 Earnings Snapshot - New Haven Register

PDS Biotechnology: Q2 Earnings Snapshot - San Antonio Express-News

PDS Biotechnology updates market on new equity sales agreement - Investing.com

PDS Biotechnology: Q2 Earnings Snapshot - Houston Chronicle

PDS Biotechnology updates market on new equity sales agreement By Investing.com - Investing.com UK

PDS Biotechnology Enhances and Modulates Stock Sales Agreement - TipRanks

PDS Biotechnology: Q2 Earnings Snapshot - San Francisco Chronicle

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - BioSpace

PDS Biotechnology: Q2 Earnings Snapshot - Press of Atlantic City

PDS Biotech: Business Update and Q2 2024 Results - ShareCast

PDS Biotechnology: Q2 Earnings Snapshot - CTPost

PDS Biotechnology: Q2 Earnings Snapshot - Greenwich Time

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - wallstreet:online

PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results - StockTitan

PDSBPDS Biotechnology Corporation Latest Stock News & Market Updates - StockTitan

PDS Biotechnology (PDSB) Set to Announce Earnings on Tuesday - MarketBeat

PDS Biotechnology (PDSB) Set to Announce Quarterly Earnings on Tuesday - Defense World

PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting - StockTitan

PDS Biotech to Announce Second Quarter Financial Results on August 13, 2024 - StockTitan

PDS Biotech Announces Abstract Accepted for Presentation at ESMO Congress 2024 - StockTitan

HC Wainwright Reiterates “Buy” Rating for PDS Biotechnology (NASDAQ:PDSB) - Defense World

Henry Schein Inc. (HSIC) Stock: Uncovering a 52-Week Range and Trading Volume - The InvestChronicle

PDS Biotechnology Corporation’s Shares Reel: -10.53% Quarterly Revenue Decline Amid 118.48M Market Cap - The InvestChronicle

PDS Biotechnology Corporation (PDSB) Clinical Program Update Conference Call (Transcript) - Seeking Alpha

Earnings call: PDS Biotech outlines plans for Versamune HPV trials - Investing.com

Ratios in Focus: Analyzing PDS Biotechnology Corporation (PDSB)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

PDS Biotech advances to phase 3 trial for HPV cancer therapy - Investing.com

Cervical Cancer Pipeline Update 2024: FDA Approvals, - openPR

PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer - StockTitan

PDS Biotech to Host Clinical Program Update Conference Call on August 1, 2024, at 8 a.m. Eastern Time - StockTitan

Who are the leading innovators in oncolytic viral proteins for the pharmaceutical industry? - Pharmaceutical Technology

PDS Biotech to Participate at BTIG Virtual Biotechnology Conference - StockTitan

$26.56

1.26%

$196.11

1.22%

$28.98

9.71%

$69.58

1.94%

$127.27

3.16%

$538.98

0.25%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Open in MarketWatch | Open in EDGAR | Open in Reuters